P. Christopher Lowe

Affiliations

  • Director at Vincerx Pharma Inc. (VINC), 2022-08-26
  • Interim Ceo, Coo & Cfo at Cortexyme Inc. (CRTX), 2022-03-04
  • President And Ceo at Inspyr Therapeutics Inc. (NSPX), 2016-08-18
  • Interim Cfo at Hansen Medical Inc (HNSN), 2016-07-30
  • Cfo And Chief Business Officer at Anthera Pharmaceuticals Inc (ANTH), 2013-05-21
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VINC $1.65 11,600 $19,138.84 40,000 2022-08-25 Filing
VINC $1.65 18,400 $30,299.28 28,400 2022-08-24 Filing
VINC $12.66 3,600 $45,576.00 10,000 2021-06-30 Filing
VINC $12.59 6,400 $80,576.00 6,400 2021-06-29 Filing
HNSN $1.44 20,000 $28,890.00 42,500 2014-05-20 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CRTX $98.50 4,963 $488,855.50 60,000 2021-10-05 Filing
CRTX $98.90 2,077 $205,415.30 30,000 2021-08-16 Filing
CRTX $97.28 1,100 $107,008.00 32,077 2021-08-16 Filing
CRTX $96.32 2,330 $224,425.60 33,177 2021-08-16 Filing
CRTX $95.02 7,335 $696,971.70 35,507 2021-08-16 Filing